Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Tools
Werbung:
Marktanalyse - Analgesics in Austria
Euromonitor
7 / 2012
31 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Österreich |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
The category of analgesics was influenced by two important factors in 2011. Firstly, the strong flu season in Austria towards the end of 2010 led to increased consumption of analgesics. Within this, aspirin was very successful as Austrians tend to buy aspirin for relief from headaches, fever and other flu-related symptoms. Secondly, the strong performance of ibuprofen also had an impact on the positive development of analgesics. Recent studies in Austria revealed that ibuprofen is much more...
Euromonitor International's Analgesics in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Analgesics in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN AUSTRIA
Euromonitor International
July 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
Table 4 Analgesics Company Shares by Value 2007-2011
Table 5 Analgesics Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Dr A & L Schmidgall AG in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 1 Dr A & L Schmidgall GmbH & Co KG: Key Facts
Summary 2 Dr A & L Schmidgall GmbH & Co KG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Dr A & L Schmidgall GmbH & Co KG: Competitive Position 2011
Kwizda Pharma GmbH in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 4 Kwizda Pharma GmbH: Key Facts
Summary 5 Kwizda Pharma GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Kwizda Pharma GmbH: Competitive Position 2011
Wellness Co Gmbh, the in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 7 The Wellness Co GmbH: Key Facts
Company Background
Production
Competitive Positioning
Summary 8 The Wellness Co GmbH: Competitive Position 2011
Executive Summary
Good Performance of Consumer Health
Hectic Lifestyles Compared With Health and Wellness
Multinationals Lead Sales
Pharmacists Prevail, Internet Retailing Growing
Modest Future Ahead
Key Trends and Developments
Busier Lifestyles Drive the Sales of Self-medication
Demographic Changes: Producers Increasingly Target Over 50s
Healthier Lifestyles As Philosophy of Living
Unhealthy Eating Habits Lead To High Obesity Rates
Pharmacies and Internet Important Channels of Distribution
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Penetration of Private Label by Category 2006-2011
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 9 OTC - Switches 2009-2011
Definitions
Sources
Summary 10 Research Sources
Euromonitor International
July 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
Table 4 Analgesics Company Shares by Value 2007-2011
Table 5 Analgesics Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Dr A & L Schmidgall AG in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 1 Dr A & L Schmidgall GmbH & Co KG: Key Facts
Summary 2 Dr A & L Schmidgall GmbH & Co KG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Dr A & L Schmidgall GmbH & Co KG: Competitive Position 2011
Kwizda Pharma GmbH in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 4 Kwizda Pharma GmbH: Key Facts
Summary 5 Kwizda Pharma GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Kwizda Pharma GmbH: Competitive Position 2011
Wellness Co Gmbh, the in Consumer Health (austria)
Strategic Direction
Key Facts
Summary 7 The Wellness Co GmbH: Key Facts
Company Background
Production
Competitive Positioning
Summary 8 The Wellness Co GmbH: Competitive Position 2011
Executive Summary
Good Performance of Consumer Health
Hectic Lifestyles Compared With Health and Wellness
Multinationals Lead Sales
Pharmacists Prevail, Internet Retailing Growing
Modest Future Ahead
Key Trends and Developments
Busier Lifestyles Drive the Sales of Self-medication
Demographic Changes: Producers Increasingly Target Over 50s
Healthier Lifestyles As Philosophy of Living
Unhealthy Eating Habits Lead To High Obesity Rates
Pharmacies and Internet Important Channels of Distribution
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Penetration of Private Label by Category 2006-2011
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 9 OTC - Switches 2009-2011
Definitions
Sources
Summary 10 Research Sources
- Analgesics in Argentina
- Analgesics in Canada
- Analgesics in Denmark
- Analgesics in Guatemala
- Analgesics in Hong Kong, China
- Analgesics in Norway
- Analgesics in Tunisia
- Analgesics in Turkey
- Aneurysmal Subarachnoid Hemorrhage (SAH) – Pipeline Review, H1 2013
- Brain Ischemia – Pipeline Review, H1 2013
- Cellulite – Pipeline Review, H1 2013
- Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2013
- Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
- Cough, Cold and Allergy (Hay Fever) Remedies in Canada
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
- Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
- Cough, Cold and Allergy (Hay Fever) Remedies in Norway
- Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
- Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:


